Cadent Therapeutics
Dec 17, 2020
Mitochondria destruction for Cancer Treatment; Atsena raises USD 55 Million financings; Novartis and Cadent Therapeutics collaboration; Neuron23’s strategy to tackle CNS disorders
Mitochondria destruction can help in Cancer Treatment Human cells require structures known as mitochondria for the generation of energy for their biochemical activities. Researchers at the Karolinska Institutet in Sweden thought that destroying these could be a strategy for cancer treatment. Follo...
Read More...
-Agonist.png "Toll-like Receptors Agonist")
